Explore our elite portfolio of clinically-proven implants manufactured using advanced biomaterials and automated Swiss CNC production lines.
The shifting paradigm of femoral fracture fixation in international trauma care centers.
Femoral fractures remain one of the most critical trauma indications globally, driven by high-energy accidents in younger populations and geriatric falls in rapidly aging societies. Over the past decade, the clinical gold standard has transitioned decisively toward intramedullary nailing. This method offers superior biomechanical load-sharing properties, preserves the periosteal blood supply, and facilitates earlier weight-bearing compared to traditional plate fixation.
Distributors and hospital procurement bodies face persistent pressure to reduce surgical costs while maintaining strict safety outcomes. This commercial dynamic has fueled the expansion of specialized OEM and ODM partnerships. Healthcare brands increasingly rely on external manufacturing entities to leverage specialized R&D infrastructure and supply chain networks, delivering regulatory-compliant trauma components at sustainable unit economics.
Moventra Medical Technology (China) Co., Ltd. – Leading the way in precision orthopedic manufacturing.
Moventra Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of orthopedic medical devices and surgical solutions. Established in 2017, the company is dedicated to delivering innovative, high-quality products for trauma, spine, joint reconstruction, sports medicine, and orthopedic surgical procedures.
With a modern manufacturing facility covering 18,600 m², Moventra integrates advanced CNC machining, precision manufacturing, automated production lines, and strict quality management systems to ensure every product meets international medical standards. Our commitment to continuous innovation enables us to provide reliable OEM and ODM services for global medical device brands, distributors, and healthcare institutions.
| Operation Details | Specifications & Capabilities |
|---|---|
| Company Name | Moventra Medical Technology (China) Co., Ltd. |
| Brand Identifier | Moventra |
| Year of Establishment | 2017 |
| Production Floor Area | 18,600 m² |
| Annual Export Volume | USD 23.8 Million |
| Direct Export Tenure | 7 Years |
| Quality Management Mandate | 100% Comprehensive Quality Inspection Prior to Packaging |
| Validation Protocols | Dimensional Metrology, Material Spectrometry, Surface Roughness Inspection, Mechanical Fatigue Profiling, Cleanroom Sterility Audits |
| Quality Assurance Inspectors | 48 dedicated certified QA/QC professionals |
| Core Business Model | Manufacturer, Advanced OEM & ODM Customization, Export Operations |
| Key Geographic Outlets | North America, Western & Eastern Europe, South America, Middle East, Southeast Asia, Australia |
| Supply Network Partners | 1,120 global supply partners |
| Target Clientele | Orthopedic Brands, Specialized Medical Distributors, Trauma Hospitals, Tender-based GPOs |
| Development Capabilities | Biomechanical Modeling, Rapid Additive Prototyping, Custom Instrumentation Design, FEA Simulation |
| Customization Latitude | Custom Labeling, Specialty Sterilization Packaging, Custom Sizing, Prototype-to-Production Scalability |
| New Product Pipelines (YoY) | 156 new product variations and instruments launched last year |
Advancing biomechanical efficiency and clinical performance through advanced engineering metallurgy.
Modern femoral intramedullary nails are configured with a distinct anatomic curvature (typically 1.5m to 2.0m radius of curvature) to prevent anterior cortex perforation. Our R&D team utilizes advanced Finite Element Analysis (FEA) to define stress distributions across the distal and proximal interlocking holes, reducing the risk of construct breakage under cyclic loading.
We work exclusively with raw materials such as Medical Grade Titanium Alloy (Ti-6Al-4V ELI) adhering to ASTM F136 standards. This alloy delivers the optimal balance of biocompatibility, high fatigue strength, and a lower modulus of elasticity, helping to mitigate stress shielding and promote healthy bone remodeling.
Our platform supports multiple proximal configuration modes, including standard locking, reconstruction locking for femoral neck fractures, and dynamic compression options. The instrumentation is designed for ease of use, with radiolucent carbon fiber targeting guides that reduce surgical times and radiation exposure for the clinical team.
Leveraging localized cluster advantages to ensure a stable supply of implants to global markets.
Operating from our 18,600 m² facility in China, Moventra leverages local medical manufacturing ecosystems. By consolidating raw material supply, precision tooling, and chemical post-processing within a unified geographic cluster, we insulate our operations against global supply chain disruptions.
Our automated manufacturing workflows utilize multi-axis Swiss-type lathe configurations alongside integrated milling stations. This high level of automation reduces human intervention, ensuring consistent high tolerances (within ± 0.005mm) across every batch of distal locking screws, end caps, and intramedullary shafts we produce.
For global OEMs, this operational model translates to shorter lead times, consistent material certifications, and the ability to scale up production rapidly during unexpected demand spikes.
Adapting implant geometry and surgical workflows to diverse clinical environments globally.
In municipal level-1 trauma centers, rapid stabilization is key. Our antegrade femoral nails feature a user-friendly insertion system that simplifies surgical placement. Standard locking patterns quickly achieve stable fixation, even in complex comminuted diaphyseal fractures.
Fragility fractures in osteoporotic bone require specialized construct behavior. Our reconstruction locking options allow dual lag screws to be guided securely through the femoral head, preventing cut-out and providing stable fixation for older patients.
For distal third femur fractures, supracondylar fractures, or in patients with ipsilateral hip replacements, our retrograde femoral nail offers a robust clinical solution. It preserves the proximal bone stock while maintaining stability at the distal articular block.
Meeting stringent quality systems and regulatory pathways to ensure patient safety and simplify market entry.
Moventra operates in strict accordance with ISO 13485:2016 medical device quality management standards. Our cleanrooms are monitored to verify particulate levels, bioburden, and endotoxins, ensuring that all non-sterile and sterile-packaged implants meet international clinical guidelines.
To assist our international distributors with import registration, we provide comprehensive technical documentation. This includes material mill sheets, biocompatibility profiles, mechanical testing data, packaging validation studies, and certificates of free sale.
Browse our expanded range of orthopedic products, covering spine, trauma, and specialized instrumentation.
Common questions from orthopedic distributors, procurement officers, and engineering teams.
Moventra Medical
